{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:35:01Z","timestamp":1782311701379,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T00:00:00Z","timestamp":1437004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40618-015-0354-z","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T04:52:33Z","timestamp":1436935953000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes"],"prefix":"10.1007","volume":"39","author":[{"given":"A.","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rigolon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pichiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pernigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bergamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zoppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,16]]},"reference":[{"key":"354_CR1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0140-6736(11)61514-6","volume":"379","author":"GY Lip","year":"2012","unstructured":"Lip GY, Tse HF, Lane DA (2012) Atrial fibrillation. Lancet 379:648\u2013661","journal-title":"Lancet"},{"key":"354_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS (2006) Secular trends in incidence of atrial fibrillation in Olmsted Country, Minnesota, 1980\u20132000, and implications on the projections for future prevalence. Circulation 114:119\u2013125","journal-title":"Circulation"},{"key":"354_CR3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","volume":"11","author":"F Rahman","year":"2014","unstructured":"Rahman F, Kwan GF, Benjamin EJ (2014) Global epidemiology of atrial fibrillation. Nat Rev Cardiol 11:639\u2013654","journal-title":"Nat Rev Cardiol"},{"key":"354_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7\u201313","journal-title":"Ann Intern Med"},{"key":"354_CR5","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang D-H, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811\u20131821","journal-title":"N Engl J Med"},{"key":"354_CR6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF03346733","volume":"34","author":"G Zoppini","year":"2011","unstructured":"Zoppini G, Targher G, Bonora E (2011) The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects. A narrative review. J Endocrinol Invest 34:881\u2013886","journal-title":"A narrative review. J Endocrinol Invest"},{"key":"354_CR7","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1212\/01.wnl.0000277468.10236.f1","volume":"69","author":"DJ Schretlen","year":"2007","unstructured":"Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, Jinnah HA (2007) Serum uric acid and brain ischemia in normal elderly adults. Neurology 69:1418\u20131423","journal-title":"Neurology"},{"key":"354_CR8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","volume":"164","author":"LK Niskanen","year":"2004","unstructured":"Niskanen LK, Laaksonen DE, Nyyss\u00f6nen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546\u20131551","journal-title":"Arch Intern Med"},{"key":"354_CR9","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.2337\/dc09-0625","volume":"32","author":"G Zoppini","year":"2009","unstructured":"Zoppini G, Targher G, Negri C, Stoico V, Perrone F, Muggeo M, Bonora E (2009) Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 32:1716\u20131720","journal-title":"Diabetes Care"},{"key":"354_CR10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","volume":"61","author":"DI Jalal","year":"2013","unstructured":"Jalal DI, Chonchol M, Chen W, Targher G (2013) Uric acid as a target of therapy in CKD. Am J Kidney Dis 61:134\u2013146","journal-title":"Am J Kidney Dis"},{"key":"354_CR11","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1016\/j.ijcard.2013.06.067","volume":"168","author":"TF Chao","year":"2013","unstructured":"Chao TF, Hung CL, Chen SJ, Wang KL, Chen TJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen SA (2013) The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 168:4027\u20134032","journal-title":"Int J Cardiol"},{"key":"354_CR12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.numecd.2014.03.012","volume":"24","author":"SY Chuang","year":"2014","unstructured":"Chuang SY, Wu CC, Hsu PF, Chia-Yu Chen R, Liu WL, Hsu YY, Pan WH (2014) Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan. Nutr Metab Cardiovasc Dis 24:1020\u20131026","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"354_CR13","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354:2473\u20132483","journal-title":"N Engl J Med"},{"key":"354_CR14","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC, AHA Task Force Members (2014) 2014 AHA\/ACC\/HRS guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130:2071\u20132104","journal-title":"Circulation"},{"key":"354_CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jelectrocard.2008.02.013","volume":"41","author":"AP Vanezis","year":"2008","unstructured":"Vanezis AP (2008) Bhopal R (2008) Validity of electrocardiographic classification of left ventricular hypertrophy across adult ethnic groups with echocardiography as a standard. J Electrocardiol 41:404\u2013412","journal-title":"J Electrocardiol"},{"key":"354_CR16","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.hrthm.2014.04.003","volume":"11","author":"L Tamariz","year":"2014","unstructured":"Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM (2014) Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 11:1102\u20131108","journal-title":"Heart Rhythm"},{"key":"354_CR17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjcard.2013.04.012","volume":"112","author":"F Valbusa","year":"2013","unstructured":"Valbusa F, Bertolini L, Bonapace S, Zenari L, Zoppini G, Arcaro G, Byrne CD (2013) Targher G (2013) Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 112:499\u2013504","journal-title":"Am J Cardiol"},{"key":"354_CR18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","volume":"99","author":"M Kanbay","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759\u2013766","journal-title":"Heart"},{"key":"354_CR19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/10715762.2012.747677","volume":"47","author":"I Pape\u017e\u00edkov\u00e1","year":"2013","unstructured":"Pape\u017e\u00edkov\u00e1 I, Pekarov\u00e1 M, Kol\u00e1\u0159ov\u00e1 H, Klinke A, Lau D, Baldus S, Lojek A, Kubala L (2013) Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res 47:82\u201388","journal-title":"Free Radic Res"},{"key":"354_CR20","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739\u20131742","journal-title":"Kidney Int"},{"key":"354_CR21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","volume":"59","author":"P Puddu","year":"2012","unstructured":"Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A (2012) Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol 59:235\u2013242","journal-title":"J Cardiol"},{"key":"354_CR22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 26:269\u2013275","journal-title":"J Hypertens"},{"key":"354_CR23","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","volume":"16","author":"DH Kang","year":"2005","unstructured":"Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553\u20133562","journal-title":"J Am Soc Nephrol"},{"key":"354_CR24","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","volume":"104","author":"MK Chung","year":"2001","unstructured":"Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR (2001) C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104:2886\u20132891","journal-title":"Circulation"},{"key":"354_CR25","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","volume":"108","author":"RJ Aviles","year":"2003","unstructured":"Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108:3006\u20133010","journal-title":"Circulation"},{"key":"354_CR26","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","volume":"120","author":"KK Patton","year":"2009","unstructured":"Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, Gottdiener JS, Kronmal RA (2009) N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular health study. Circulation 120:1768\u20131774","journal-title":"Circulation"},{"key":"354_CR27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","volume":"121","author":"RB Schnabel","year":"2010","unstructured":"Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, Meigs JB, Tofler GH, Selhub J, Jacques PF, Wolf PA, Magnani JW, Ellinor PT, Wang TJ, Levy D, Vasan RS, Benjamin EJ (2010) Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 121:200\u2013207","journal-title":"Circulation"},{"key":"354_CR28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","volume":"12","author":"YF Hu","year":"2015","unstructured":"Hu YF, Chen YJ, Lin YJ, Chen SA (2015) Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol 12:230\u2013243","journal-title":"Nat Rev Cardiol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0354-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0354-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0354-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T23:03:42Z","timestamp":1559516622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0354-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,16]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0354-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,16]]}}}